+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech



Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech



Journal of Neurodevelopmental Disorders 5(1): 29



Childhood apraxia of speech (CAS) is a rare, severe, persistent pediatric motor speech disorder with associated deficits in sensorimotor, cognitive, language, learning and affective processes. Among other neurogenetic origins, CAS is the disorder segregating with a mutation in FOXP2 in a widely studied, multigenerational London family. We report the first whole-exome sequencing (WES) findings from a cohort of 10 unrelated participants, ages 3 to 19 years, with well-characterized CAS. As part of a larger study of children and youth with motor speech sound disorders, 32 participants were classified as positive for CAS on the basis of a behavioral classification marker using auditory-perceptual and acoustic methods that quantify the competence, precision and stability of a speaker's speech, prosody and voice. WES of 10 randomly selected participants was completed using the Illumina Genome Analyzer IIx Sequencing System. Image analysis, base calling, demultiplexing, read mapping, and variant calling were performed using Illumina software. Software developed in-house was used for variant annotation, prioritization and interpretation to identify those variants likely to be deleterious to neurodevelopmental substrates of speech-language development. Among potentially deleterious variants, clinically reportable findings of interest occurred on a total of five chromosomes (Chr3, Chr6, Chr7, Chr9 and Chr17), which included six genes either strongly associated with CAS (FOXP1 and CNTNAP2) or associated with disorders with phenotypes overlapping CAS (ATP13A4, CNTNAP1, KIAA0319 and SETX). A total of 8 (80%) of the 10 participants had clinically reportable variants in one or two of the six genes, with variants in ATP13A4, KIAA0319 and CNTNAP2 being the most prevalent. Similar to the results reported in emerging WES studies of other complex neurodevelopmental disorders, our findings from this first WES study of CAS are interpreted as support for heterogeneous genetic origins of this pediatric motor speech disorder with multiple genes, pathways and complex interactions. We also submit that our findings illustrate the potential use of WES for both gene identification and case-by-case clinical diagnostics in pediatric motor speech disorders.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056942306

Download citation: RISBibTeXText

PMID: 24083349

DOI: 10.1186/1866-1955-5-29


Related references

A Diagnostic Marker to Discriminate Childhood Apraxia of Speech From Speech Delay: III. Theoretical Coherence of the Pause Marker with Speech Processing Deficits in Childhood Apraxia of Speech. Journal of Speech Language and Hearing Research 60(4): S1135, 2017

Is the amount of practice an important variable in the treatment of Childhood Apraxia of Speech (CAS): The importance of production frequency in therapy for childhood apraxia of speech. Evidence-Based Communication Assessment and Intervention 6(2): 66-75, 2012

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity. Cell Reports 25(6): 1446-1457, 2018

Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations. Annals of Oncology 27(4): 738-744, 2016

Genetic Candidate Variants in Two Multigenerational Families with Childhood Apraxia of Speech. Plos one 11(4): E0153864, 2016

The number of candidate variants in exome sequencing for Mendelian disease under no genetic heterogeneity. Computational and Mathematical Methods in Medicine 2013: 179761, 2013

Whole Exome Sequencing Reveals a Large Genetic Heterogeneity and Revisits the Causes of Hypertrophic Cardiomyopathy. Circulation. Genomic and Precision Medicine 12(5): E002500, 2019

Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity. Bmc Medical Genetics 14: 118, 2013

Identification of the Genetic Cause for Childhood Disintegrative Disorder by Whole-Exome Sequencing. Neuroscience Bulletin 33(2): 251-254, 2017

Speech Inconsistency in Children With Childhood Apraxia of Speech, Language Impairment, and Speech Delay: Depends on the Stimuli. Journal of Speech, Language, and Hearing Research 60(5): 1194-1210, 2017

BioGranat-IG A network analysis tool to suggest mechanisms of genetic heterogeneity from exome sequencing data. 2013

BioGranat-IG: a network analysis tool to suggest mechanisms of genetic heterogeneity from exome-sequencing data. Bioinformatics 29(6): 733-741, 2013

Simultaneous natural speech and AAC interventions for children with childhood apraxia of speech: lessons from a speech-language pathologist focus group. Augmentative and Alternative Communication 31(1): 63-76, 2015

Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer. International Journal of Cancer 142(5): 927-939, 2018

Network-Informed Gene Ranking Tackles Genetic Heterogeneity in Exome-Sequencing Studies of Monogenic Disease. Human Mutation 36(12): 1135-1144, 2015